Judge to decide on admission of evidence as part of litigation that has knocked billions off pharma group’s value ...

Sanofi, drugmaker behind Zantac, has agreed to settle 4,000 lawsuits The suits claim that discontinued Zantac contained cancer-causing chemicals READ MORE: Has heartburn pill that has been given ...

Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users ...

opens new tab has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did not disclose ...

French pharmaceutical giant Sanofi said Thursday it had reached a preliminary agreement on settling thousands of US lawsuits concerning its heartburn drug Zantac. A spokesman said that all bodily ...

Zantac, developed by GSK and Warner-Lambert, hit the US market as a prescription drug in 1983 before becoming an over-the-counter heartburn treatment in 1996. It was owned by several companies ...

Sanofi SAN-1.00%decrease; red down pointing triangle said it reached an agreement in principle to settle about 4,000 claims around allegations that its heartburn drug Zantac caused cancer.

New Jersey-based manufacturer Sanofi has reached an agreement to settle 4,000 lawsuits linking the active ingredient in Zantac - rantidine - to cancers. Zantac, an over-the-counter pill for ...

Sanofi will pay more than US$100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn ...